"Arno" ductus arteriosus group
Taiwan·Risk Class 2·Arrow Internacional de Chihuahua S.A. de C.V.;; Arrow International LLC (subsidiary of Teleflex Incorporated)·Registered Jan 19, 2016 – Jan 19, 2026Expired- Analysis ID
- aae7101bd8da618793a5fa65723c89ef
- Customs Code
- DHA05602814900
- Manufacturer Country
- Mexico;;United States
- Authorized Representative
- TELEFLEX MEDICAL TAIWAN LTD.
- Intended Use
- Details are as detailed as the Chinese copy of the approved version. Details such as the approved Chinese instruction manual (the original label, instruction manual or packaging approved on February 4, 105 will be recycled and invalidated). Change of original label, instruction manual or packaging and indications: details as the approved Chinese instruction manual (the original label, instruction manual or packaging approved on October 22, 110 shall be withdrawn and invalidated).
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.1200 診斷用血管內導管
- Import Information
- import
- Registration Date
- Jan 19, 2016
- Expiry Date
- Jan 19, 2026
Top companies providing products similar to ""Arno" ductus arteriosus group"
Recently registered similar products
Access comprehensive regulatory information for "Arno" ductus arteriosus group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number aae7101bd8da618793a5fa65723c89ef and manufactured by Arrow Internacional de Chihuahua S.A. de C.V.;; Arrow International LLC (subsidiary of Teleflex Incorporated). The authorized representative in Taiwan is TELEFLEX MEDICAL TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including ARROW INTERNATIONAL INC., Arrow Internacional de Chihuahua S.A. de C.V.;; Arrow International LLC (subsidiary of Teleflex Incorporated), and 3 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.